Jun-Ichi Kira Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

11/2019	Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
1/2019	Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis.
1/2017	Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun-Ichi Kira Research Topics

Disease

34	Multiple Sclerosis 01/2024 - 05/2004
19	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 11/2010
16	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2023 - 08/2013
11	Polyneuropathies (Polyneuropathy) 01/2023 - 10/2015
11	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2013
9	Inflammation (Inflammations) 09/2023 - 05/2004
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 11/2006
7	Relapsing-Remitting Multiple Sclerosis 01/2023 - 12/2012
7	Myelitis 06/2021 - 05/2004
6	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 02/2015
5	Pain (Aches) 07/2023 - 01/2018
5	Guillain-Barre Syndrome 01/2023 - 08/2013
5	Muscle Weakness 01/2021 - 04/2004
5	Neuralgia (Stump Neuralgia) 01/2021 - 11/2016
4	Multiple System Atrophy 05/2023 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2017
4	Neuroinflammatory Diseases 06/2021 - 08/2017
4	Stroke (Strokes) 11/2019 - 12/2016
3	Gliosis 01/2024 - 08/2018
3	Ataxia (Dyssynergia) 05/2023 - 11/2016
3	Disease Progression 01/2023 - 01/2018
3	Necrosis 01/2021 - 11/2010
3	Hypertrophy 01/2021 - 10/2015
3	Heart Failure 10/2020 - 10/2016
3	Muscular Diseases (Myopathy) 10/2020 - 05/2009
3	Cognitive Dysfunction 01/2020 - 01/2016
3	Ischemic Stroke 11/2019 - 12/2016
3	Atrophy 06/2019 - 04/2004
3	Hyperalgesia 01/2019 - 11/2016
3	Infections 01/2019 - 02/2004
3	Parkinson Disease (Parkinson's Disease) 08/2018 - 01/2017
3	POEMS Syndrome (Syndrome, POEMS) 10/2016 - 06/2008
3	Paraproteinemias (Monoclonal Gammopathy) 10/2016 - 06/2008
3	Opticospinal Multiple Sclerosis 01/2016 - 05/2004
2	Chronic Progressive Multiple Sclerosis 09/2023 - 01/2013
2	Myasthenia Gravis 01/2023 - 05/2020
2	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 12/2022 - 06/2002
2	Leukocytosis (Pleocytosis) 10/2022 - 04/2010
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2021 - 01/2018
2	Aspiration Pneumonia 01/2021 - 01/2018
2	Cerebral Hemorrhage 07/2020 - 05/2020
2	Thrombosis (Thrombus) 05/2020 - 11/2016
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2020 - 12/2016
2	Ischemia 01/2020 - 01/2018
2	Insulin Resistance 01/2020 - 01/2017
2	Deglutition Disorders (Dysphagia) 01/2018 - 04/2010

Drug/Important Bio-Agent (IBA)

25	AntibodiesIBA 01/2023 - 05/2004
22	Immunoglobulin G (IgG)IBA 01/2023 - 04/2010
20	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2003
13	AutoantibodiesIBA 01/2023 - 11/2010
9	Connexin 43 (Connexin43)IBA 01/2024 - 11/2011
7	AntigensIBA 01/2019 - 06/2008
6	Myelin-Oligodendrocyte GlycoproteinIBA 07/2023 - 01/2016
6	EnzymesIBA 05/2023 - 03/2007
6	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021 - 01/2020
6	CytokinesIBA 01/2021 - 01/2013
6	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 04/2010
5	ConnexinsIBA 01/2024 - 01/2020
5	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021 - 10/2012
5	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2010
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2016
4	Peptides (Polypeptides)IBA 11/2021 - 01/2018
4	plexinIBA 01/2021 - 01/2018
4	Prednisolone (Predate)FDA LinkGeneric 10/2020 - 04/2010
4	Complement System Proteins (Complement)IBA 01/2020 - 11/2010
4	ChemokinesIBA 11/2019 - 01/2013
3	Interleukin-6 (Interleukin 6)IBA 09/2023 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 12/2022 - 10/2016
3	HLA-DRB1*04 antigenIBA 12/2021 - 01/2016
3	AllergensIBA 01/2021 - 06/2008
3	LectinsIBA 01/2020 - 02/2015
3	Aquaporin 4IBA 01/2020 - 08/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019 - 01/2017
3	Immunoglobulin E (IgE)IBA 11/2019 - 05/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 04/2010
3	Natalizumab (Tysabri)FDA Link 06/2017 - 01/2017
3	ImmunosorbentsIBA 12/2016 - 03/2007
2	iguratimodIBA 09/2023 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 01/2023 - 01/2019
2	Myelin-Associated GlycoproteinIBA 01/2023 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 05/2004
2	Indicators and Reagents (Reagents)IBA 11/2022 - 01/2016
2	GoldIBA 10/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2017
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 11/2019
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2017
2	Interleukin-13IBA 01/2021 - 11/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2019
2	Fingolimod Hydrochloride (FTY720)FDA Link 07/2020 - 01/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2020 - 11/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 10/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2017
2	BQ 788IBA 01/2019 - 11/2016
2	Connexin 30IBA 08/2018 - 01/2018
2	Superoxide Dismutase-1IBA 01/2018 - 02/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2017

Therapy/Procedure

18	Therapeutics 05/2020 - 03/2004
8	Immunotherapy 01/2023 - 12/2004
2	Thrombectomy 08/2021 - 12/2016